Chime Biologics inks over $190m
Chime Biologics, a China-based provider of outsourcing services for biopharmaceutical development and manufacturing, has raised over $190 million in funding.
Chime Biologics, a China-based provider of outsourcing services for biopharmaceutical development and manufacturing, has raised over $190 million in funding.
Copyright PEI Media
Not for publication, email or dissemination